How Myriad Genetics, Inc. (MYGN) Stock converts water flow into cash flow
Leerink Partners raised the price target for the Myriad Genetics, Inc. (NASDAQ:MYGN) stock from “a Market perform” to “an Outperform”. The rating was released on May 08, 2024, according to finviz. The research report from Wells Fargo has initiated the stock to Equal Weight, with a price target set at $20. The stock was initiated […]
The Myriad Genetics, Inc. (MYGN) Stock expansion path ahead
Piper Sandler raised the price target for the Myriad Genetics, Inc. (NASDAQ:MYGN) stock to “a Neutral”. The rating was released on December 21, 2023, according to finviz. The research report from Guggenheim has initiated the stock to Buy, with a price target set at $23. The stock was initiated by Wolfe Research, who disclosed in […]
A Tale from the Dusty Corner: Myriad Genetics, Inc. (MYGN) Stock
Piper Sandler raised the price target for the Myriad Genetics, Inc. (NASDAQ:MYGN) stock to “a Neutral”. The rating was released on December 21, 2023, according to finviz. The research report from Guggenheim has initiated the stock to Buy, with a price target set at $23. The stock was initiated by Wolfe Research, who disclosed in […]
Growing at an Unbelievable Rate: Myriad Genetics, Inc. (MYGN) Stock
Piper Sandler raised the price target for the Myriad Genetics, Inc. (NASDAQ:MYGN) stock to “a Neutral”. The rating was released on December 21, 2023, according to finviz. The research report from Guggenheim has initiated the stock to Buy, with a price target set at $23. The stock was initiated by Wolfe Research, who disclosed in […]
The market value of Myriad Genetics, Inc. (MYGN) Stock is expected to soar in the coming months
Piper Sandler raised the price target for the Myriad Genetics, Inc. (NASDAQ:MYGN) stock to “a Neutral”. The rating was released on December 21, 2023, according to finviz. The research report from Guggenheim has initiated the stock to Buy, with a price target set at $23. The stock was initiated by Wolfe Research, who disclosed in […]
Myriad Genetics, Inc. (NASDAQ:MYGN) stock Market Value Reached at $1.76 billion: What Happened?
Piper Sandler raised the price target for the Myriad Genetics, Inc. (NASDAQ:MYGN) stock to “a Neutral”. The rating was released on December 21, 2023, according to finviz. The research report from Guggenheim has initiated the stock to Buy, with a price target set at $23. The stock was initiated by Wolfe Research, who disclosed in […]
